Skip to content
Case Study

Food & Beverage Manufacturing Supply Chain Risk

From Tier 1 Visibility to Full Value Chain Control

Mapped 250+ suppliers across 3+ tiers in under 7 days revealing hidden dependencies and multi-million euro exposure to disruption and commodity volatility.

 

Client Challenge

A leading European dairy and ingredients manufacturer operating across global markets faced increasing complexity across its value chain from agricultural sourcing through to ingredient processing and international distribution.

food-1

Despite strong procurement and supplier relationships, critical dependencies beyond tier 1 were largely invisible, leaving the organisation exposed to:

  • Commodity price volatility
  • Supplier concentration risk
  • Climate and geographic disruption
  • Increasing ESG and assurance requirements
Investigating these risks was slow, manual, and fragmented across teams, making it difficult to act early or quantify financial impact.

At the board level, there was no clear, defensible link between supply chain risk and revenue exposure, limiting confidence in strategic sourcing and reporting decisions.

Scope and Objectives

Goal: Rapidly discover, visualize, and mitigate value chain risks across core product lines—while linking supply chain exposure directly to financial impact and improving audit readiness.cisions.

Key Inputs

  • Bills of Materials (BOMs) for selected dairy and ingredient product lines
  • Tier 1 supplier and sourcing data
  • Partial operational and production site data
  • Regional procurement inputs
 
Case Study

The Approach

 
1. Discover & Visualize
  • Ingested BOMs and supplier data to map multi-tier supplier networks (tier 1–3+)
  • Identified upstream dependencies across agricultural inputs, processing facilities, and logistics networks
  • Delivered a live, user-friendly, human-centric interactive canvas of the full value chain
pharma-cs-1
 
2. Identify Weak Spots
  • Highlighted hidden supplier concentration and geographic exposure
  • Identified risks linked to commodity volatility, climate exposure, and supplier financial health
  • Flagged single points of failure across critical ingredients and inputs
  • Quantified potential revenue and cost exposure tied to key dependencies
pharma-cs-2-1
 
3. Mitigate
  • Surfaced similarly qualified alternative suppliers across regions
  • Identified opportunities for supplier diversification, nearshoring, and dual sourcing
  • Enabled data-driven sourcing decisions balancing cost, resilience, and compliance
pharma-cs-3
 
Outcomes
  • End-to-end visibility across 250+ entities spanning multiple tiers of the value chain
  • Identification of critical supplier concentration risks across key ingredients
  • Clear linkage between supplier disruption and financial impact
  • Reduction in investigation time from weeks to days
  • Quantified multi-million euro exposure to disruption and commodity volatility
  • Improved ability to make audit-ready, defensible sourcing and materiality decisions
  • Greater confidence at board level through evidence-backed risk visibility
 

Why Attaima?

  • Speed at scale: Delivered multi-tier visibility in days, not months
  • Beyond tier 1: Uncovered hidden dependencies traditional tools and manual processes miss
  • Financial clarity: Linked value chain risk directly to revenue and cost exposure
  • Audit-ready by design: Created a defensible, traceable view of decisions and assumptions
  • Continuous monitoring: Enabled ongoing visibility across suppliers, regions, and risk signals

Next steps / ongoing work

  • Expand coverage across additional product lines and global operations
  • Integrate continuous monitoring for supplier, commodity, and reputational risks
  • Enhance scenario modelling to support long-term sourcing and resiliency strategy
food-white
“For the first time, we had a clear, defensible view of our value chain allowing us to identify risks early, quantify impact, and act with confidence.”
— Senior Procurement Leader
Mainland European F&B Manufacturer

Emblem

Learn more about how Attaima can help your pharma value chain